U.S. End Stage Renal Disease Market Size, Share & Trends Analysis Report By Treatment (Transplant, Dialysis, Peritoneal Dialysis, Hemodialysis, Wearable Artificial Kidney), And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1 Methodology and Scope
                  1.1 Market Segmentation and Scope
                      1.1.1 Treatment
                      1.1.2 Regional Scope
                      1.1.3 Estimates And Forecast Timeline
                  1.2 Research Methodology
                  1.3 Information Procurement
                      1.3.1 Purchased Database:
                      1.3.2 Gvr’s Internal Database
                      1.3.3 Secondary Sources
                      1.3.4 Primary Research
                      1.3.5 Details Of Primary Research
                  1.4 Information Or Data Analysis
                      1.4.1 Data Analysis Models
                  1.5 Market Formulation & Validation
                  1.6 Model Details
                      1.6.1 Commodity Flow Analysis (Model 1)
                          1.6.1.1 Approach 1: Commodity Flow Approach
                      1.6.2 Volume Price Analysis (Model 2)
                          1.6.2.1 Approach 2: Volume Price Analysis
                  1.7 List of Secondary Sources
                  1.8 List of Primary Sources
                  1.9 List of Abbreviations
                  1.10 Objectives
                      1.10.1 Objective 1
                      1.10.2 Objective 2
                      1.10.3 Objective 3
                      1.10.4 Objective 4
Chapter 2 Executive Summary
                  2.1 Market Outlook
                  2.2 Segment Outlook
                  2.3 Competitive Insights
                  2.4 Market Snapshot
Chapter 3 End Stage Renal Disease Market Variables, Trends & Scope
                  3.1 Market Lineage Outlook
                      3.1.1 Parent Market Outlook
                      3.1.2 Ancillary Market Outlook
                  3.2 Penetration & Growth Prospect Mapping
                  3.3 Product Pipeline Analysis
                  3.4 User Perspective Analysis
                      3.4.1 Consumer Behavior Analysis
                      3.4.2 Market Influencer Analysis
                  3.5 List Of Key End Users
                  3.6 Regulatory Framework
                      3.6.1 List Of Regulations, By Country
                  3.7 Impact Of Covid-19
                      3.7.1 Supply Chain
                      3.7.2 Changing Market Trends
                  3.8 Market Dynamics
                      3.8.1 Market Driver Analysis
                          3.8.1.1 Increasing prevalence of chronic kidney disease
                          3.8.1.2 Growing prevalence of diabetes and hypertension
                          3.8.1.3 Introduction of technologically advanced products
                          3.8.1.4 Growing government initiatives and recommendations for efficient kidney disease management
                      3.8.2 Market Restraints Analysis
                          3.8.2.1 Expensive Equipment Reducing The Affordability In Developing Countries
                          3.8.2.2 Issues Related To Product Approval And Commercialization
                      3.8.3 Market Opportunities Analysis
                          3.8.3.1 Increased demand for home care services due to COVID-19 pandemic
                  3.9 End Stage Renal Disease: Market Analysis Tools
                      3.9.1 Industry Analysis - Porter’s
                      3.9.2 Swot Analysis, By Pest
Chapter 4 End Stage Renal Disease Market: Segment Analysis, By Treatment, 2018 - 2030 (USD Million)
                  4.1 Definition and Scope
                  4.2 Treatment Market Share Analysis, 2023 & 2030
                  4.3 Segment Dashboard
                  4.4 U.S. End Stage Renal Disease Market, by Treatment, 2018 to 2030
                  4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
                      4.5.1 Transplant 
                          4.5.1.1 Transplant market, 2018 - 2030 (USD Million)
                      4.5.2 Dialysis 
                          4.5.2.1 Dialysis market, 2018 - 2030 (USD Million)
                          4.5.2.2 Peritoneal Dialysis 
                              4.5.2.2.1 Peritoneal Dialysis market, 2018 - 2030 (USD Million)
                          4.5.2.3 Hemodialysis 
                              4.5.2.3.1 Hemodialysis market, 2018 - 2030 (USD Million)
                          4.5.2.4 Wearable Artificial Kidney
                              4.5.2.4.1 Wearable Artificial Kidneymarket, 2018 - 2030 (USD Million)
Chapter 5 End Stage Renal Disease Market - Competitive Analysis
                  5.1 Recent Developments & Impact Analysis, by Key Market Participants
                      5.1.1 Ansoff Matrix
                  5.2 Company Categorization
                      5.2.1 Innovators
                      5.2.2 Market Leaders
                  5.3 Vendor Landscape
                      5.3.1 Key Customers
                      5.3.2 Major Deals And Strategic Alliances
                          5.3.2.1 New Product Launch
                          5.3.2.2 Expansion
                          5.3.2.3 Marketing & Promotions
                      5.3.3 Market Entry Strategies
                  5.4 Public Companies
                      5.4.1 Company Market Position Analysis
                      5.4.2 Competitive Dashboard Analysis
                          5.4.2.1 Market Differentiators
                  5.5 Private Companies
                      5.5.1 List Of Key Emerging Companies
                      5.5.3 Regional Network Map
                      5.5.4 Company Market Position Analysis
                  5.6 Company Profiles
                      5.6.1 NIPRO CORPORATION
                          5.6.1.1 Company overview
                          5.6.1.2 financial Performance
                          5.6.1.3 Product benchmarking
                          5.6.1.4 Strategic initiatives
                      5.6.2 FRESENIUS MEDICAL CARE AG & CO. KGAA
                          5.6.2.1 Company overview
                          5.6.2.2 Financial Performance
                          5.6.2.3 Product/Service benchmarking
                          5.6.2.4 Strategic initiatives
                      5.6.3 MEDTRONIC
                          5.6.3.1 Company overview
                          5.6.3.2 Financial performance
                          5.6.3.3 Product/Service benchmarking
                          5.6.3.4 Strategic initiatives
                      5.6.4 B. BRAUN MELSUNGEN AG
                          5.6.4.1 Company overview
                          5.6.4.2 Financial performance
                          5.6.4.3 Product benchmarking
                          5.6.4.4 Strategic initiatives
                      5.6.5 BD
                          5.6.5.1 Company overview
                          5.6.5.2 financial performance
                          5.6.5.3 Product benchmarking
                          5.6.5.4 Strategic initiatives
                      5.6.6 BAXTER
                          5.6.6.1 Company overview
                          5.6.6.2 Financial performance
                          5.6.6.3 Product benchmarking
                          5.6.6.4 Strategic initiatives
                      5.6.7 ASAHI KASEI MEDICAL CO., LTD
                          5.6.7.1 Company overview
                          5.6.7.2 Product benchmarking
                          5.6.7.3 Strategic initiatives
                      5.6.8 CANTEL MEDICAL
                          5.6.8.1 Company overview
                          5.6.8.2 financial performance
                          5.6.8.3 Product benchmarking
                          5.6.8.4 Strategic initiatives
                      5.6.9 NIKKISO CO., LTD.
                          5.6.9.1 Company overview
                          5.6.9.2 Financial performance
                          5.6.9.3 Product benchmarking
                      5.6.10 JMS CO., LTD.
                          5.6.10.1 Company overview
                          5.6.10.2 financial performance
                          5.6.10.3 Product benchmarking

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 U.S. end stage renal disease market, by treatment, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 End stage renal disease market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot (2019)
Fig. 10 Penetration & growth prospect mapping
Fig. 11 Consumer behavior analysis
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Market restraint relevance analysis (Current & future impact)
Fig. 14 Market opportunity relevance analysis (Current & future impact)
Fig. 15 Porter’s five forces analysis
Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 17 End stage renal disease market: Treatment movement analysis
Fig. 18 Segment dashboard
Fig. 19 End stage renal disease market treatment outlook: Key takeaways
Fig. 20 Transplant market, 2018 - 2030 (USD Million)
Fig. 21 Dialysis market, 2018 - 2030 (USD Million)
Fig. 22 Peritoneal dialysis market, 2018 - 2030 (USD Million)
Fig. 23 Hemodialysis market, 2018 - 2030 (USD Million)
Fig. 24 Wearable artificial kidney market, 2018 - 2030 (USD Million)
Fig. 25. Ansoff Matrix
Fig. 26 Market differentiators